newsfilter
← Latest News
PR Newswire·

Aadi Bioscience to Participate at Upcoming Investor Conferences

LOS ANGELES, Sept. 5, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ:AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with mTOR pathway